|23rd November 2020||Advisors Llc Perceptive||500,000||Open or private purchase||$12.85||$6,425,000.00|
|12th November 2020||Alexandria Forbes||7,851||Open or private sale||$15.01||$117,843.51|
|11th November 2020||Alexandria Forbes||2,498||Open or private sale||$15.02||$37,519.96|
|10th November 2020||Stuart Naylor||3,739||Open or private sale||$15.00||$56,085.00|
|10th November 2020||Alexandria Forbes||12,703||Open or private sale||$15.05||$191,180.15|
|9th November 2020||Stuart Naylor||512||Open or private sale||$15.00||$7,680.00|
|5th November 2020||Alexandria Forbes||3,981||Open or private sale||$15.03||$59,834.43|
|5th November 2020||Stuart Naylor||8,282||Open or private sale||$15.02||$124,395.64|
|29th October 2020||Joel S Marcus||50,000||Bona fide gift||$0.00|
|27th October 2020||Advisors Llc Perceptive||3,000,000||Open or private purchase||$10.00||$30,000,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
MeiraGTx Holdings Plc is a clinical-stage biotech company. It engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.